Compare Devon Energy Corp (DVN) vs State Street SPDR S&P Biotech ETF (XBI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Devon Energy Corp vs State Street SPDR S&P Biotech ETF — how do they compare? Devon Energy Corp trades at $43.24 (market cap $49.52B), while State Street SPDR S&P Biotech ETF trades at $154.4. The key difference: Devon Energy Corp pays a 2.42% dividend while State Street SPDR S&P Biotech ETF pays none, and State Street SPDR S&P Biotech ETF is trading nearer its 52-week high, Devon Energy Corp nearer its low. Which is the better fit depends on your goals.
| DVN | XBI | |
|---|---|---|
Market Cap | $49.52B | — |
Sector | Energy | Broad Market / Factor |
52-Week High | $52.07 | $164.28 |
52-Week Low | $31.74 | $85.16 |
Enterprise Value | $56.29B | — |
Dividend Yield | 2.42% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Devon Energy (DVN) trades at $43.40, down 0.75% on the day, with a bullish technical signal and strong analyst support. The stock shows robust fundamentals with a P/E of 11.96 and net income margin of 13.71%, supported by recent earnings beats. Cash flow trends improved in 2025, with net cash flow turning positive to $588 million, while the company navigates post-merger integration following the Coterra acquisition.
Outlook remains positive with a consensus price target of $60.18, implying significant upside. Key opportunities include synergy realization from the merger and disciplined capital allocation. Risks involve activist investor pressure for asset sales, oil price volatility, and execution challenges in achieving projected $2 billion in synergies by 2027.
XBI trades at $155.19, down 0.23% on the day, with a bullish technical signal from moving averages. Recent news highlights strong biotech sector momentum, with the ETF gaining nearly 17% in a month (24/7 Wall Street, 2026-07-06). Analyst consensus is neutral with a single hold rating, while technical indicators show a neutral RSI and mixed ADX signals. Support is seen near $153, with resistance at $157.
The outlook for XBI is supported by sector strength and M&A activity, but high volatility and a neutral analyst stance suggest cautious optimism. Key risks include regulatory uncertainty and macroeconomic pressures, requiring careful risk management for investors.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Devon Energy Corp
Devon Energy, based in Oklahoma City, is one of the largest independent exploration and production companies in North America. The firm's asset base is spread throughout onshore North America and includes exposure to the Delaware, STACK, Eagle Ford, Powder River Basin, and Bakken plays. At year-end 2021, Devon's proved reserves totaled 1.6 billion barrels of oil equivalent, and net production that year was 572 thousand boe/d, of which oil and natural gas liquids made up 74% of production, with natural gas accounting for the remainder.
Read more on DVN →About State Street SPDR S&P Biotech ETF
XBI is an equal-weighted ETF that tracks the U.S. biotechnology segment. It provides diversified exposure to small, mid, and large-cap biotech firms involved in drug discovery and medical research, such as Moderna and Exact Sciences.
Read more on XBI →
